Pulmozyme® (dornase alfa) is a nebulized cystic fibrosis (CF) treatment option to help manage CF symptoms. See full safety for more information.

Jul 30, 2024 · What is Pulmozyme? Pulmozyme is a synthetic protein that breaks down excess DNA in the pulmonary secretions of people with cystic fibrosis. Pulmozyme is used in people with cystic fibrosis to thin mucus in the airways. This may …

Pulmozyme (dornase alfa) is indicated for daily administration in conjunction with standard therapies for the management of cystic fibrosis (CF) patients to improve pulmonary function.

Pulmozyme (dornase alfa) is indicated, along with standard therapies, for the management of pediatric and adult patients with cystic fibrosis (CF) to improve pulmonary function.

Dornase alfa, sold under the brand name Pulmozyme, is used for the treatment of cystic fibrosis. [3] It is a recombinant human deoxyribonuclease I (rhDNase), an enzyme which selectively cleaves DNA. [3] Dornase alfa hydrolyzes the DNA present in sputum/mucus and reduces viscosity in the lungs, promoting improved clearance of secretions. [3]

Feb 29, 2024 · Pulmozyme (dornase alfa) Inhalation Solution is a synthetic protein used to improve lung function in people with cystic fibrosis by thinning pulmonary secretions and reducing the risk of respiratory tract infections. What Are Side Effects of Pulmozyme? Pulmozyme may cause serious side effects including:

PULMOZYME is a recombinant DNase enzyme indicated in conjunction with standard therapies for the management of cystic fibrosis (CF) patients to improve pulmonary function.

Find patient medical information for Pulmozyme inhalation on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

How Pulmozyme works to fight cystic fibrosis. Laboratory studies show that Pulmozyme cuts apart extracellular DNA by acting like an enzyme* naturally found in the lungs. By cutting this extracellular DNA, Pulmozyme helps make the thick, sticky mucus that …

Dec 15, 2024 · PULMOZYME is a recombinant DNase enzyme indicated in conjunction with standard therapies for the management of cystic fibrosis (CF) patients to improve pulmonary function. (1) Inhalation solution: 2.5 mg/2.5 mL (1 mg/mL) …